220
B. Therrien, G. S€uss-Fink / Inorganica Chimica Acta 357 (2004) 219–224
Switzerland. 1,2,4-Trimethyl-cyclohexadiene was pre-
pared according to published method [6].
3.53 (m, 4H), 2.95 (m, 2H), 2.27 (m, 2H), 2.05 (m, 2H),
1.97 (s, 3H), 1.92 (s, 6H), 1.76 (m, 2H), 1.71 (s, 3H), 1.50
(s, 3H), 1.39 (s, 3H), 1.25 (s, 3H), 1.06 (m, 2H), 0.95 (m,
2H), 0.83 (s, 3H), 0.55 (s, 3H), 0.04 (s, 3H), 0.01 ppm (s,
3H); 31P{1H} NMR (81 MHz, CDCl3); d ¼ 24:6 and
24.7 ppm; IR (KBr): 2954 s, 1632 w, 1438 s, 1374 m,
1094 m, 1032 m, 883 w, 748 s, 698 s, 519 s cmꢁ1; ESI-
MS: m=z: 581 [M ) Clꢁ]; elemental Anal. Calc. For
C31H41Cl2PRu (616.6), C, 60.4; H, 6.7. Found: C, 60.6;
H, 6.7%. The less soluble diastereomer 3a crystallised in
a pure form from a methanol solution of 3 at room
temperature.
2.2. Preparation of [RuCl2(1,2,4-C6H3Me3)]2 (1)
A solution of RuCl3 ꢀ nH2O (3.2 g, 12.0 mmol) and 10
equivalents of 1,2,4-trimethyl-cyclohexadiene (14.7 g,
0.12 mol) in ethanol (40 ml) was refluxed for 12 h. The
volume was then reduced to 5 ml, and the solid pre-
cipitated with ether. The red, air-stable, microcrystalline
material was isolated by filtration, giving 1 (550 mg, 0.81
mmol) in 50% yield. 1H NMR (400 MHz, CDCl3):
d ¼ 5:34 (d, 1H; CHar), 5.33 (d, 1H; CHar), 5.27 (d, 1H;
CHar), 5.25 (d, 1H; CHar), 5.00 (s, 1H; CHar), 4.99 (s,
1H; CHar), 2.17 (s, 3H, CH3), 2.16 (s, 3H, CH3), 2.11 (s,
3H, CH3), 2.10 (s, 6H, CH3), 2.09 ppm (s, 3H, CH3);
13C{1H} NMR (100 MHz, CDCl3): d ¼ 96:97, 96.93,
95.75, 95.67, 90.81, 90.78, 84.57, 84.52, 80.90, 80.86,
79.63, 79.53, 19.17, 17.74, 17.21 ppm; IR (KBr): 3043 m,
2918 m, 1621 w, 1531 w, 1448 s, 1376 s, 1122 w, 1031 s,
889 w, 734 w, 631 w cmꢁ1; ESI-MS: m=z: 606 [M + Naþ];
elemental Anal. Calc. For C18H24Cl4Ru2 (584.21), C,
37.0; H, 4.1. Found: C, 36.8; H, 4.2%.
2.5. Preparation of [RuCl2(1,2,4-C6H3Me3) (dppfc)
RuCl2(1,2,4-C6H3Me3)] (4)
A solution of 1 (58 mg, 0.1 mmol) and 1,10-
bis(diphenylphosphino)ferrocene (55 mg, 0.1 mmol) in
methanol (10 ml) was heated at 60 °C for 4 h. The
solvent was reduced to 2 ml, and the product purified
on silica gel plates (CH2Cl2/acetone, 15:1) to afford
[RuCl2(1,2,4-C6H3Me3)(dppfc)RuCl2(1,2,4-C6H3Me3)]
4 as an orange solid (35 mg, 0.03 mmol). Yield: 31%.
1H NMR (200 MHz, CDCl3): d ¼ 7:67 (m, 8H, PPh2),
7.36 (m, 12H, PPh2), 5.37 (s, 2H, CHar), 4.14 (m, 2H,
CHar), 4.11 (m, 2H, CHar), 4.03 (m, 4H, CHFc), 3.50 (s,
4H, CHFc), 2.15 (s, 6H, CH3), 1.86 (s, 6H, CH3), 1.61
ppm (s, 6H, CH3); 31P{1H} NMR (81 MHz, CDCl3);
d ¼ 20:7 ppm; IR (KBr): 1630 w, 1434 s, 1161 m, 1095
m, 1026 m, 752 s, 698 s, 545 m cmꢁ1; ESI-MS: m=z:
1161 [M + Naþ]; elemental Anal. Calc. For
C52H52Cl4FeP2 Ru2(1138.74), C, 54.8; H, 4.6. Found:
C, 55.0; H, 4.7%.
2.3. Preparation of [RuCl2(1,2,4-C6H3Me3)(PPh3)]
(2)
A solution of 1 (290 mg, 0.5 mmol) and triphenyl-
phosphine (270 mg, 1.0 mmol) in methanol (20 ml) was
heated at 60 °C for 3 h. Then the solvent was evaporated
to dryness to afford quantitatively [RuCl2(1,2,4-
1
C6H3Me3)(PPh3)] (2) as an orange solid. H NMR (200
MHz, CDCl3): d ¼ 7:80 (m, 6H; PPh3), 7.40 (m, 9H;
PPh3), 5.40 (s, 1H, CHar), 4.29 (m, 1H, CHar), 4.18 (m,
1H, CHar), 2.22 (s, 3H, CH3), 2.01 (s, 3H, CH3), 1.86
ppm (s, 3H, CH3); 13C{1H} NMR (50 MHz,
CDCl3): ¼ 134.65, 134.55, 134.36, 130.48, 128.32,
128.14, 107.57, 97.65, 96.30, 94.67, 86.11, 83.78, 17.93,
16.84, 16.20 ppm; 31P{1H} NMR (81 MHz, CDCl3);
d ¼ 28:5 ppm; IR (KBr): 1630 m, 1479 w, 1436 s, 1375
w, 1089 m, 1023 m, 753 s, 698 s, 528 s cmꢁ1; ESI-MS:
m=z: 519 [M ) Clꢁ]; elemental Anal. Calc. For
C27H27Cl2P1Ru2 (554.46), C, 58.5; H, 4.9. Found: C,
58.6; H, 4.8%.
2.6. X-ray crystallographic study
Crystals of (rac)-2 and 3a were mounted on a Stoe
Image Plate Diffraction system equipped with a /
circle goniometer, using Mo Ka graphite monochro-
ꢁ
mated radiation (k ¼ 0:71073 A) with / range 0°–
100°, increment of 0.9° and 0.7°, respectively, 2h range
ꢁ
from 2.0° to 26°, Dmax–Dmin ¼ 12:45–0:81 A. The
structures were solved by direct methods using the
programme SHELXS-97 [7]. The refinement and all
further calculations were carried out using SHELXL-
97 [8]. The H-atoms were included in calculated po-
sitions and treated as riding atoms using the SHELXL
default parameters. The non-H atoms were refined
anisotropically, using weighted full-matrix least-
square on F 2. Crystallographic details are summarised
in Table 1. Figures were drawn with the ORTEP
program [9].
2.4. Preparation of [RuCl2(1,2,4-C6H3Me3)(nmdpp)]
(3)
A solution of (1S,2S,5R)-(+)- neomenthyldiphenyl-
phosphine (110 mg, 0.34 mmol) and 1 (100 mg, 0.17
mmol) in ethanol (20 ml) was refluxed for 2 h. The so-
lution was evaporated under vacuum to give
[RuCl2(1,2,4-C6H3Me3)(nmdpp)] (182 mg, 0.29 mmol).
3
CCDC-212744 (rac)-2 and 212743 3a contain the
supplementary crystallographic data for this paper. These
1
Yield: 87%. H NMR (200 MHz, CDCl3): d ¼ 7:90 (m,
8H, PPh2), 7.55 (m, 4H, PPh2), 7.25 (m, 8H, PPh2), 5.16
(s, 1H, CHar), 5.06 (s, 1H, CHar), 4.34 (m, 2H, CHar),